ORLANDO, FL, February 19, 2017 -- Inferscience, provider of Clinical Decision Support solutions, will showcase innovative technology to improve the physician and patient experience at the point of care at the HIMSS17 Conference and Exhibition (Booth #7785). Conference attendees with have the opportunity to demo the Infera® advanced clinical decision support system.
Clinical quality officers have a tough job. They have to change the behavior of people providing care in their health systems. This means doing everything they can to remove the barriers that keep healthcare professionals from providing the best care possible.
Our team was so energized by the StartUp Health showcase hosted by athenahealth in SF this past Tuesday evening. We have never been surrounded by so many like-minded individuals who are on the same shared mission to transform healthcare. We were blown away by every one of the 33 companies who pitched their startups that we didn’t even feel the pressure of pitching Inferscience in under a minute!
Inferscience is pleased to announce its acceptance into the athenahealth athenaMDP program and the inclusion of Infera, our next-generation clinical decision support system (CDSS) in the athenaMDP Marketplace (here). Users of athenaClinicals can begin using Infera immediately.
As many of us know in the healthcare community, clinical decision support (CDS) functionality is a meaningful use (MU) requirement for EHRs. I suppose the goal of the authors of this requirement is to enable physicians to provide quality care by following established care guidelines for appropriate screening, monitoring, etc.
This is the second article in a series of two articles addressing management of seizures. A link to the first article is provided below:
Female urinary incontinence is a common condition that affects women of all ages. Involuntary loss of urine can cause physical, psychological, and social consequences, and can lead to significant lifestyle restrictions. Its effects can range from bothersome to severely debilitating, but in many cases, simple measures such as lifestyle modification and medications are effective. It is therefore important to make a prompt diagnosis and early treatment to avoid its complications.
What should Allscripts users know about Infera?
This is the first article in a series of two articles addressing management of seizures. A link to the second article is provided below:
The PAMA (Protecting Access to Medicare Act 2014) law signed by president Obama and passed in April 2014, mandates that physicians consult appropriate use criteria (AUC) before ordering advanced imaging tests. While originally intended for implementation on January 1, 2017, Medicare has postponed the implementation for now, but given the spiraling costs of healthcare, we can be certain that sooner or later providers will need to show that appropriate use criteria are met for advanced imaging tests.
About Inferscience's Founder
With over 12 years of experience working with electronic health records (EHRs), Dr. Sunil Nihalani observed how EHRs are being under-utilized in clinical practices. Moreover, the HCC Coding & risk adjustment coding capabilities have been lacking in the clinician’s workflow. Dr. Nihalani’s vision is an HCC Coding tool solution that integrates with leading EHRs and HIT systems to analyze patient records and claims information to help physicians and coders capture and audit HCC codes within their workflows. With Inferscience’s HCC Assistant, Physicians can document HCC codes and plan of care information in real-time during the patient encounter. Now, one solution enables both payers and providers to succeed in today's value-based care market.
Learn more about Inferscience and HCC Coding Assistant by visiting our products page here.